Fluticasone prop HFA 110 MCG 12GM
Ended Awarded
- Contract number
- SPE2DB25FNJRZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,498
Award facts
- Contract value 100% obligated
- $1,498.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is part of the DLA Medical Supply Chain's pharmaceutical procurement operations, which leverage AmerisourceBergen's position as a major pharmaceutical distributor serving military and veteran healthcare systems. The Fluticasone Propionate inhaler is a corticosteroid medication used in respiratory treatment protocols within the Defense Health Agency and broader federal military medical programs. AmerisourceBergen's SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare requirements worldwide, demonstrating the company's critical role in federal medical procurement.
Quick answers
Who was awarded contract SPE2DB25FNJRZ?
SPE2DB25FNJRZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FNJRZ worth?
The government has obligated $1,498 on SPE2DB25FNJRZ.
Is contract SPE2DB25FNJRZ an order under another contract?
Yes. SPE2DB25FNJRZ is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNJRZ competed?
The extent of competition for SPE2DB25FNJRZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award